ArticleFrontiers in oncology2022

Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients.

Yuanyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.